Dr Balaji Ganeshan presents TexRAD at the prestigious Beijing Society of Radiology Conference – Feedback Plc (FDBK).
Dr Balaji Ganeshan presents TexRAD at the prestigious Beijing Society of Radiology Conference. On Saturday September 9th 2017, Dr Balaji Ganeshan, CEO of TexRAD Ltd and Director of New Business at Feedback Plc gave a keynote lecture entitled “TexRAD Texture Analysis of CT and MR images – ready for prime time?” at the prestigious Beijing Radiation Academic […]
Feedback (FDBK) – Trevor Brown shareholding
Feedback announces that it has been advised by Trevor Brown that he is now beneficially interested in 40,929,111 Ordinary Shares, representing 16.61 per cent of the issued ordinary shares of the Company. For further information, please contact: Feedback plc Alastair Riddell Tel: 01954 718072 Allenby Capital Limited (Nominated Adviser and Joint Broker) David Worlidge / […]
TexRAD Texture Analysis of CT and MR images – ready for prime time at Beijing Radiation Academic Annual Conference – Feedback (FDBK)
Balaji Ganeshan, CEO of TexRAD and Director of New Business for Feedback plc our parent company, is presenting a session entitled “TexRAD Texture Analysis of CT and MR images – ready for prime time?” at the prestigious Beijing Radiation Academic Annual Conference starting September 9th. This part of our ongoing development of awareness of the […]
Feedback (FDBK) – Total Voting Rights
Feedback plc (AIM: FDBK), announces that the Company’s issued share capital as at the date of this announcement comprises 246,416,584 ordinary shares, with one voting right per share. The Company holds does not hold any shares in treasury. The total number of Ordinary Shares and voting rights in the Company is 246,416,584. The above figure may be used […]
Feedback (FDBK) subsidiary CCI signs exclusive agreement with Boya Digital Technology (Beijing) to distribute TexRAD in China
Feedback plc is pleased to announce that its subsidiary, Cambridge Computed Imaging Ltd, has signed an exclusive distributor agreement with Boya Digital Technology (Beijing) Co. Ltd., based in Beijing, China, for sales and distribution of its TexRAD® texture analysis research software in the People’s Republic of China. Boya is an approved vendor to GE Healthcare China, Beijing and is […]
Commercial Director appointed for CCI Ltd – Feedback (FDBK)
Feedback plc are pleased to welcome Ian McLellan as Commercial Director for CCI Ltd. This new role will develop the market and sales channels for our products, supporting sales growth including the launch of next generation TexRAD products as part our commitment to invest in our Brands. Ian has joined CCI after working closely with […]
Feedback (FDBK) – Trevor Brown shareholding
Feedback announces that it has been advised by Trevor Brown that he is now beneficially interested in 43,454,111 Ordinary Shares, representing 17.66 per cent of the issued ordinary shares of the Company. The Company has been advised by Trevor Brown that he remains prepared to enter into an orderly market agreement. No such agreement, however, […]
Feedback (FDBK) – Issue of equity to TexRAD founder
Feedback plc (AIM: FDBK), the medical imaging software company, announces that it has today issued 350,000 ordinary shares of 0.25 pence each pursuant to an exercise of warrants by a founder of TexRAD Limited, conditional on admission of the Warrant Shares to trading on AIM. The Warrants Shares were converted a price of 1.25 pence […]
Endometrial Carcinoma: MR Imaging-based Texture Model for Preoperative Risk Stratification – Feedback (FDBK).
Feedback (FDBK) – Endometrial Carcinoma: MR Imaging-based Texture Model for Preoperative Risk Stratification – Preliminary Analysis. Source Ueno Y, et al. Radiology. 2017. PURPOSE: To evaluate the associations among mathematical modeling with the use of magnetic resonance (MR) imaging-based texture features and deep […]
Prostate-specific membrane antigen PET-MRI validation of MR textural analysis for detection of transition zone prostate cancer? – Feedback (FDBK)
Feedback (FDBK) – Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer? Source Bates A, et al. Eur Radiol. 2017. OBJECTIVES: To validate MR textural analysis (MRTA) for detection of transition zone (TZ) prostate cancer through […]